Invention Grant
- Patent Title: Anti-cancer agent containing a diacylphosphatidylethanolamine as an active ingredient
-
Application No.: US15106401Application Date: 2014-12-19
-
Publication No.: US09770458B2Publication Date: 2017-09-26
- Inventor: Tomoyuki Nishizaki , Takashi Nakano
- Applicant: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Applicant Address: JP Hyogo
- Assignee: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Current Assignee: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Current Assignee Address: JP Hyogo
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2013-264714 20131221
- International Application: PCT/JP2014/083657 WO 20141219
- International Announcement: WO2015/093588 WO 20150625
- Main IPC: A61K31/685
- IPC: A61K31/685
Abstract:
The present invention provides an anti-cancer agent, a cancer cell death inducing agent, a protein phosphatase 2A activation enhancing agent, a protein tyrosine phosphatase 1B activation enhancing agent and the like, each containing 1,2-dipalmitoleoyl-sn-glycero-3-phosphoethanolamine as an active ingredient.
Public/Granted literature
- US20170027968A1 ANTI-CANCER AGENT Public/Granted day:2017-02-02
Information query
